In vitro bactericidal activity of cefpirome in combination with vancomycin against Staphylococcus aureus and coagulase-negative Staphylococcus.
Raymond
J
J
Service Microbiologie, Hôpital Saint Vincent de Paul, Paris, France.
Vedel
G
G
Bergeret
M
M
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002511:Cephalosporins / Q000494:pharmacology*; D003030:Coagulase / Q000378:metabolism; D004347:Drug Interactions; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination / Q000494:pharmacology*; D006801:Humans; D008826:Microbial Sensitivity Tests; D013210:Staphylococcus / Q000187:drug effects / Q000201:enzymology; D013211:Staphylococcus aureus / Q000187:drug effects*; D014640:Vancomycin / Q000494:pharmacology*; D000097572:Cefpirome
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D003030:Coagulase; D014640:Vancomycin; D000097572:Cefpirome